Physician Photo

Jeffrey A. Gelfand, MD

  • Phone: 617-724-0082
Infectious Diseases
Department of Medicine
Clinical Interests
Urinary Tract Infections
Sepsis and Septic Shock
Infectious diseases
Boston: Massachusetts General Hospital
Medical Education
MD, Tufts University School of Medicine
Residency, The Johns Hopkins Hospital
Fellowship, National Institute of Health
Board Certifications
Infectious Disease, American Board of Internal Medicine
Internal Medicine, American Board of Internal Medicine
Allergy & Immunology, American Board of Internal Medicine
Foreign Languages
Patient Age Group
Accepting New Patients
Accepting New Patients

Creating hope from loss

Inspired by his wife's memory, Jeffrey Gelfand, MD, and his MGH colleagues set out to create a vaccine to attack tumors in patients already diagnosed with cancer.

Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

A novel approach to cancer immunotherapy may provide a cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma. A protein engineered by MGH investigators to combine a molecule targeting a tumor antigen with an immune-function stimuating protein prolonged survival in animal models of both tumors.

Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-724-0082
Phone 2: 617-726-1796
Fax: 617-726-7416